Search | IOVS | ARVO Journals

Showing 1 – 20 of 108

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Clinical Trials February 2025

A Single-Center Sham and Active-Controlled Double-Blind Randomized Crossover Trial of the Magnetic Levator Prosthesis for Severe Blepharoptosis

PDF

Kevin E. Houston; Shrinivas Pundlik; Prerana Shivshanker; Alex R. Bowers; Sarah LaRosa; Mara Robinson; James Chodosh; Lynn Brandes; Patrick Lee; Eleftherios I. Paschalis
TAGS: eyelid ptosis, prostheses, safety, adverse event
Trans. Vis. Sci. Tech.. 2025; 14(2):15. https://doi.org/10.1167/tvst.14.2.15

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Examining Racial Disparities in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Paul de Bustros; Mohammadali Ashraf; James Chodosh; Harris Ahmed; James Taekyoon Kwan; Hajirah N Saeed

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2847.

ARVO Annual Meeting Abstract June 2024

Non-viral gene delivery of crystallin gamma S protects retinal cells and increases their proliferation during inflammation

Jyoti Sharma; Fengyang Lei; Mohammad Mirazul Islam; Pedro De La Torre Marquez; Bin Yan; Toshio Narimatsu; Da Sun; Jie Liu; James Chodosh; Demetrios G. Vavvas; Graeme J Wistow; Artur Indzhykulian; zheng rong lu; Eleftherios I Paschalis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4452.

ARVO Annual Meeting Abstract June 2024

Attribution of Causality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Asha Parvathaneni; Liliya Benchetrit; Derek Metcalfe; James Taekyoon Kwan; Yandong Bian; Tave Van Zyl; Hajirah N Saeed; James Chodosh

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5069.

ARVO Annual Meeting Abstract June 2023

Association of human antigen class I and class II genes with Stevens-Johnson syndrome/toxic epidermal necrolysis in a United States population

Abdelrahman M. Elhusseiny; James Kwan; Rebecca Zhang; Mayumi Ueta; Derek Metclafe; Ramy Rashad; Swapna Shanbagh; Janey L Wiggs; James Chodosh; Hajirah Saeed

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5398.

ARVO Annual Meeting Abstract June 2023

Minimally invasive keratoprosthesis (mi-KPro) for vision restoration after severe chemical injury.

Jyoti Sharma; Thomas H Dohlman; Chengxin Zhou; Peter York; Fengyang Lei; Jie Liu; Robert Woods; Claes Dohlman; James Chodosh; Roberto Pineda; Eleftherios I Paschalis

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5136.

ARVO Annual Meeting Abstract June 2023

Systematic approach to analyzing protein structure predicts mutations associated with inherited retinal disease

Blake M. Hauser; Yuyang Luo; Anusha Nathan; James Chodosh; Lucia Sobrin; Eric A Pierce; Bruce Walker; Gaurav Gaiha; Elizabeth Rossin

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3267.

ARVO Annual Meeting Abstract June 2023

Simple innervated 3D corneal constructs for in vitro testing

Mohammad Mirazul Islam; Amrita Saha; Farzana Afrose Trisha; Miguel González Andrades; Hirak Patra; May Griffith; James Chodosh; Jaya Rajaiya

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2354.

ARVO Annual Meeting Abstract June 2022

Potential role of high mobility group box 1 in formation of corneal subepithelial infiltrates in adenovirus keratitis

Amrita Saha; Mohammad Mirazul Islam; Ashrafali Mohamed Ismail; Xiaohong Zhou; James Chodosh; Jaya Rajaiya

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3245 – A0280.

ARVO Annual Meeting Abstract June 2022

Expected Visual Field Outcomes Following Boston Keratoprosthesis Type I and II in Eyes without Glaucoma

Charlotte Crist; Claes H. Dohlman; James Chodosh; Teresa C Chen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4354 – A0291.

ARVO Annual Meeting Abstract June 2022

Acute Ophthalmic Manifestations in Mycoplasma Induced Rash and Mucositis

Abdelrahman M. Elhusseiny; Ramy Rashad; Swapna S Shanbhag; James Chodosh; Hajirah N. Saeed

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3946 – A0226.

ARVO Annual Meeting Abstract June 2022

Compensatory expression of Crystallin γS in retinal microglia neutralizes endotoxin-induced neuroinflammation

Fengyang Lei; Naiwen Cui; Chengxin Zhou; Yamei Cai; Nikolaos Efstathiou; James Chodosh; Demetrios G. Vavvas; Huidan Zhang; David Weitz; Graeme J. Wistow; Eleftherios I Paschalis

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3517.

ARVO Annual Meeting Abstract June 2022

Chemical Crosslinker-free Pro-regenerative Corneal Implants

Mohammad Mirazul Islam; Alexandru Chivu; Dina Abusamra; Sina Sharifi; Amrita Saha; Sumit Chowdhuri; Claes H. Dohlman; Debapratim Das; Pablo Argueso; Jaya Rajaiya; Hirak Patra; James Chodosh

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):95 – A0193.

ARVO Annual Meeting Abstract June 2022

HSP-Specific T Cell Counts in Boston Keratoprosthesis Type I Patients

Chhavi Saini; Kin-Sang Cho; Julia Devlin; Li Pan; Shuhong Jiang; Eleftherios I Paschalis; James Chodosh; Dongfeng Chen; Lucy Q. Shen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):943 – A0412.

ARVO Annual Meeting Abstract June 2022

Structural and Functional Assessment of Glaucoma Progression in Patients with Boston Keratoprosthesis Type 1

Alexandra Castillejos; Chhavi Saini; James Chodosh; Lucy Q. Shen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):828.

ARVO Annual Meeting Abstract June 2021

The Relationship of the Timing to Ophthalmology Consultation on Acute Ocular Severity in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Susannah Paine; James Taekyoon Kwan; James Chodosh; Hajirah N. Saeed

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1706.

ARVO Annual Meeting Abstract June 2021

Highly Multiplexed Broad Pathogen Detection Assay for Diagnosis of Ocular Infections

Paulo J.M. Bispo; Lawson Ung; James Chodosh; Lucia Sobrin; Michael S Gilmore

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3460.

ARVO Annual Meeting Abstract June 2021

Acute and Chronic Ocular Manifestations of Stevens-Johnson Syndrome in HIV-positive vs. HIV-negative Patients

Momoko K Ponsetto; Derek Metcalfe; James Chodosh; Hajirah N. Saeed

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3450.

ARVO Annual Meeting Abstract June 2021

The Relationship of the Atopic Triad and Acute Ocular Outcomes in Patients with Stevens-Johnson Syndrome

Harris Ahmed; James Taekyoon Kwan; Momoko Kimura; Tony Succar; James Chodosh; Hajirah N. Saeed

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3448.

ARVO Annual Meeting Abstract June 2021

The Effect of Systemic Immunomodulatory Therapy on Acute Outcomes of Stevens-Johnson Syndrome

James Taekyoon Kwan; Harris Ahmed; Momoko Kimura; James Chodosh; Hajirah N. Saeed

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3446.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

A Single-Center Sham and Active-Controlled Double-Blind Randomized Crossover Trial of the Magnetic Levator Prosthesis for Severe Blepharoptosis

Examining Racial Disparities in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Non-viral gene delivery of crystallin gamma S protects retinal cells and increases their proliferation during inflammation

Attribution of Causality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Association of human antigen class I and class II genes with Stevens-Johnson syndrome/toxic epidermal necrolysis in a United States population

Minimally invasive keratoprosthesis (mi-KPro) for vision restoration after severe chemical injury.

Systematic approach to analyzing protein structure predicts mutations associated with inherited retinal disease

Simple innervated 3D corneal constructs for in vitro testing

Potential role of high mobility group box 1 in formation of corneal subepithelial infiltrates in adenovirus keratitis

Expected Visual Field Outcomes Following Boston Keratoprosthesis Type I and II in Eyes without Glaucoma

Acute Ophthalmic Manifestations in Mycoplasma Induced Rash and Mucositis

Compensatory expression of Crystallin γS in retinal microglia neutralizes endotoxin-induced neuroinflammation

Chemical Crosslinker-free Pro-regenerative Corneal Implants

HSP-Specific T Cell Counts in Boston Keratoprosthesis Type I Patients

Structural and Functional Assessment of Glaucoma Progression in Patients with Boston Keratoprosthesis Type 1

The Relationship of the Timing to Ophthalmology Consultation on Acute Ocular Severity in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Highly Multiplexed Broad Pathogen Detection Assay for Diagnosis of Ocular Infections

Acute and Chronic Ocular Manifestations of Stevens-Johnson Syndrome in HIV-positive vs. HIV-negative Patients

The Relationship of the Atopic Triad and Acute Ocular Outcomes in Patients with Stevens-Johnson Syndrome

The Effect of Systemic Immunomodulatory Therapy on Acute Outcomes of Stevens-Johnson Syndrome

To View More...

You must be signed into an individual account to use this feature.